Patients with lupus nephritis who received hydroxychloroquine demonstrated a significantly lower risk for glomerular ...

Researchers assessed the incidence of diabetes in relation to hydroxychloroquine and glucocorticoid doses among patients with primary Sjögren syndrome.

The Food and Drug Administration on Monday revoked emergency use authorization for giving the malaria drug hydroxychloroquine, and a related drug chloroquine, for COVID-19. The drugs were heavily ...

Use of hydroxychloroquine during pregnancy in patients with systemic lupus erythematosus (SLE) is associated with a reduced risk for preeclampsia, according to a recent nationwide cohort study. A ...

Hydroxychloroquine use in patients with lupus nephritis was significantly associated with greater improvement in eGFR slope over the first 5 years than over 10 years. Hydroxychloroquine (HCQ) use in ...

The FDA has ended an emergency use authorization (EUA) order for hydroxychloroquine, saying that the agency has determined that drug is "unlikely to be effective in treating COVID-19." In the ...